OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mucosal-Associated Invariant T Cells in Autoimmune Diseases
Asako Chiba, Goh Murayama, Sachiko Miyake
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Interaction Between the Microbiota, Epithelia, and Immune Cells in the Intestine
Hisako Kayama, Ryu Okumura, Kiyoshi Takeda
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 23-48
Open Access | Times Cited: 510

Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE
Luc Van Kaer, J. Luke Postoak, Chuan Wang, et al.
Cellular and Molecular Immunology (2019) Vol. 16, Iss. 6, pp. 531-539
Open Access | Times Cited: 118

The Pathogenesis of Ankylosing Spondylitis: an Update
Susanne Juhl Pedersen, Walter P. Maksymowych
Current Rheumatology Reports (2019) Vol. 21, Iss. 10
Closed Access | Times Cited: 92

The Immune Landscape of Visceral Adipose Tissue During Obesity and Aging
Saad Khan, Yi Tao Chan, Xavier S. Revelo, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 80

The Gut–CNS Axis in Multiple Sclerosis
Atsushi Kadowaki, Francisco J. Quintana
Trends in Neurosciences (2020) Vol. 43, Iss. 8, pp. 622-634
Open Access | Times Cited: 80

Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosis
Ina Mexhitaj, Moffat Nyirenda, Rui Li, et al.
Brain (2019) Vol. 142, Iss. 3, pp. 617-632
Open Access | Times Cited: 76

MAIT cells regulate NK cell-mediated tumor immunity
Emma V. Petley, Hui‐Fern Koay, Melissa A. Henderson, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 66

Biological functions and therapeutic applications of human mucosal-associated invariant T cells
Ying Fang, Yuning Chen, Shaoqiang Niu, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 1

A cross talk between dysbiosis and gut-associated immune system governs the development of inflammatory arthropathies
Alexander Kalinkovich, Gregory Livshits
Seminars in Arthritis and Rheumatism (2019) Vol. 49, Iss. 3, pp. 474-484
Closed Access | Times Cited: 70

A Critical Role for Mucosal-Associated Invariant T Cells as Regulators and Therapeutic Targets in Systemic Lupus Erythematosus
Goh Murayama, Asako Chiba, Hitoshi Suzuki, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 58

Double‐negative T cells: Setting the stage for disease control or progression
Teresiama Velikkakam, Kenneth J. Gollob, Walderez O. Dutra
Immunology (2021) Vol. 165, Iss. 4, pp. 371-385
Open Access | Times Cited: 52

Gut dysbiosis and multiple sclerosis
Daisuke Noto, Sachiko Miyake
Clinical Immunology (2020) Vol. 235, pp. 108380-108380
Open Access | Times Cited: 50

Engineering Human MAIT Cells with Chimeric Antigen Receptors for Cancer Immunotherapy
Mikail Dogan, Ece Karhan, Lina Kozhaya, et al.
The Journal of Immunology (2022) Vol. 209, Iss. 8, pp. 1523-1531
Open Access | Times Cited: 37

Systematic review with meta‐analysis: risk of new onset IBD with the use of anti‐interleukin‐17 agents
Akihiro Yamada, Jingzhou Wang, Yuga Komaki, et al.
Alimentary Pharmacology & Therapeutics (2019) Vol. 50, Iss. 4, pp. 373-385
Closed Access | Times Cited: 53

TGF-β in Renal Fibrosis: Triumphs and Challenges
Yue-Yu Gu, Xusheng Liu, Xiao‐Ru Huang, et al.
Future Medicinal Chemistry (2020) Vol. 12, Iss. 9, pp. 853-866
Closed Access | Times Cited: 44

Immunological abnormalities in patients with primary biliary cholangitis
Wentao Ma, Dekun Chen
Clinical Science (2019) Vol. 133, Iss. 6, pp. 741-760
Closed Access | Times Cited: 43

New insights into MAIT cells in autoimmune diseases
Qi Fan, He Nan, Zhe Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114250-114250
Open Access | Times Cited: 13

Considering the ‘Alternatives’ for Next-Generation Anti-Staphylococcus aureus Vaccine Development
Eóin C. O’Brien, Rachel M. McLoughlin
Trends in Molecular Medicine (2019) Vol. 25, Iss. 3, pp. 171-184
Closed Access | Times Cited: 40

T Cells in Preterm Infants and the Influence of Milk Diet
Thomas Sproat, Rebecca P. Payne, Nicholas D. Embleton, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 38

Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis
Vincenzo Ronca, Clara Mancuso, Chiara Milani, et al.
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 2, pp. 659-671
Closed Access | Times Cited: 35

Circulating Soluble Factors and T-Cell Subsets as Immunological Predictors of Therapy Response in Human Cutaneous Leishmaniasis
Amanda Braga Figueiredo, Kátia L.P. Morais, Israel Tojal da Silva, et al.
The Journal of Infectious Diseases (2025)
Closed Access

Defenders or defectors: mucosal-associated invariant T cells in autoimmune diseases
Mitchell Kronenberg, Thomas Riffelmacher
Current Opinion in Immunology (2025) Vol. 93, pp. 102542-102542
Closed Access

Unveiling the immunological landscape of disseminated tuberculosis: a single-cell transcriptome perspective
Zhen Gong, Hongxiang Xu, Qiao Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Page 1 - Next Page

Scroll to top